RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Social determinants of health (SDOH) and other predictors in treatment initiation with cdk4/6 inhibitors in Medicare patients with hr+/her2 metastatic breast cancer (MBC)
Goyal, R. K., Candrilli, S. D., Abughosh, S. M., Chen, H., Holmes, H. M., & Johnson, M. L. (2023). Social determinants of health (SDOH) and other predictors in treatment initiation with cdk4/6 inhibitors in Medicare patients with hr+/her2 metastatic breast cancer (MBC). Value in Health, 26(12), S286-S286.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.